Both GLP1 and GIP act indirectly on white adipose tissue, whereas GIP directly regulates fat and amino acid metabolism and inflammation within brown adipose tissue
Tirzepatide is a synthetic peptide drug approved through the New Drug Application (NDA) pathway, not a biologic
As consequences of polymorphism of MTHFR , reduction of MTHFR enzymatic activity would cause impaired methylation as well as deficiency of folate
The GLP-1 compounders situation is drawing enough attention that former FDA commissioner Robert Califf, during a media roundtable discussion before leaving office, addressed the issue
GLP-1s are an approved treatment for those with a BMI over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea
Our findings suggest that compared to insulin therapy, the higher drug acquisition, pharmacy, and outpatient costs associated with the real-world use of a GLP-1RA is offset by a reduction in healthcare-related expenses associated with emergency room visits and inpatient admissions owing to reduced risks of all-cause mortality and hospitalized hypoglycemia